Adolescent girl with down syndrome and lumbar cutaneous melanoma

Pediatric Dermatology

Volumn 31, Issue 1, 2014, Pages 108-109

  Satgé, Daniel ^a   Dimoux Dime, Guy ^a   Godard, William ^b   De Fréminville, Bénédicte ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Institut de Pathologie du Forez   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CASE REPORT; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FOLLICULITIS; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; SKIN DEFECT; SUN EXPOSURE; THIGH; TUMOR VOLUME; YOUNG ADULT;

BIOPSY; DOWN SYNDROME; FEMALE; HUMANS; LUMBOSACRAL REGION; MELANOMA; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84891856032     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01764.x     Document Type: Article

References (7)

1. Satgé D, Sommelet D, Geneix A, et al., A tumor profile in Down syndrome. Am J Med Genet 1998; 78: 207-216.
2. Hasle H, Clemmensen IH, Mikkelsen M,. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000; 355: 165-169.
3. Nakano J, Muto M, Arikawa K, et al., Acral lentiginous melanoma associated with Down's syndrome. J Dermatol 1993; 20: 59-60.
4. Jafarian F, Powell J, Kokta V, et al., Malignant melanoma in childhood and adolescence: report of 13 cases. J Am Acad Dermatol 2005; 53: 816-822.
5. Kuphal S, Bosserhoff A,. Recent progress in understanding the pathology of malignant melanoma. J Pathol 2009; 219: 400-409.
6. Barrett JH, Iles MM, Harland M, et al., Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011; 43: 1108-1113.
7. Mushinski JF, Nguyen P, Stevens LM, et al., Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem 2009; 284: 15206-15214.